J Cortez1, K Makker1, D F Kraemer2, J Neu3, R Sharma1, M L Hudak1. 1. Division of Neonatology, Department of Pediatrics, University of Florida College of Medicine - Jacksonville, Jacksonville, FL, USA. 2. Center for Health Equity and Quality Research, University of Florida College of Medicine - Jacksonville, Jacksonville, FL, USA. 3. Division of Neonatology, Department of Pediatrics, University of Florida College of Medicine - Gainesville, Gainesville, FL, USA.
Abstract
OBJECTIVE: Human milk (donor milk (DM) and/or maternal milk (MM)) feedings protect against late onset sepsis (LOS), necrotizing enterocolitis (NEC) and death. However, DM lacks many anti-infective components of MM. Therefore, we studied exclusive MM feedings to evaluate the full effect of human milk on infectious and other outcomes in premature infants. STUDY DESIGN: All infants born before 33 weeks postmenstrual age (PMA) who received exclusive (>95%) MM or exclusive preterm formula (PF) were included in this prospective investigation. RESULTS: Sixty-three infants (53%) received MM and 55 infants (47%) received PF. Both groups had similar baseline characteristics. Infants in the MM group achieved full enteral nutrition sooner (14±8 vs 19±15 days, P<0.03) and required a shorter duration of central venous lines (14±10 vs 22±21, P<0.005). Fewer infants in the MM group developed LOS (9 vs 19, P<0.05) and pneumonia (8 vs 16, P<0.05) than PF infants. Only one MM and five PF infants developed NEC (Bell stage ⩾II). Logistic regression analysis using PMA and prolonged rupture of membranes as covariates demonstrated an increased rate of NEC (odds ratio=8.85, CI=1.01 to 25.17, P=0.048) in PF infants. Periventricular leukomalacia (PVL) was more common in PF (4 vs 0, P=0.04) than in MM infants. CONCLUSION: Feedings of MM advanced more rapidly and were associated with fewer infections than PF. A possible protective effect of MM against PVL, not previously described, may be related to its immune and anti-inflammatory components.
OBJECTIVE:Human milk (donor milk (DM) and/or maternal milk (MM)) feedings protect against late onset sepsis (LOS), necrotizing enterocolitis (NEC) and death. However, DM lacks many anti-infective components of MM. Therefore, we studied exclusive MM feedings to evaluate the full effect of human milk on infectious and other outcomes in premature infants. STUDY DESIGN: All infants born before 33 weeks postmenstrual age (PMA) who received exclusive (>95%) MM or exclusive preterm formula (PF) were included in this prospective investigation. RESULTS: Sixty-three infants (53%) received MM and 55 infants (47%) received PF. Both groups had similar baseline characteristics. Infants in the MM group achieved full enteral nutrition sooner (14±8 vs 19±15 days, P<0.03) and required a shorter duration of central venous lines (14±10 vs 22±21, P<0.005). Fewer infants in the MM group developed LOS (9 vs 19, P<0.05) and pneumonia (8 vs 16, P<0.05) than PFinfants. Only one MM and five PFinfants developed NEC (Bell stage ⩾II). Logistic regression analysis using PMA and prolonged rupture of membranes as covariates demonstrated an increased rate of NEC (odds ratio=8.85, CI=1.01 to 25.17, P=0.048) in PFinfants. Periventricular leukomalacia (PVL) was more common in PF (4 vs 0, P=0.04) than in MM infants. CONCLUSION: Feedings of MM advanced more rapidly and were associated with fewer infections than PF. A possible protective effect of MM against PVL, not previously described, may be related to its immune and anti-inflammatory components.
Authors: Renu Sharma; Joseph J Tepas; Mark L Hudak; Daniel L Mollitt; Peter S Wludyka; Ru-Jeng Teng; Bangalore R Premachandra Journal: J Pediatr Surg Date: 2007-03 Impact factor: 2.545
Authors: Leigh R Campbell; Yi Pang; Norma B Ojeda; Baoying Zheng; Philip G Rhodes; Barbara T Alexander Journal: Pediatr Res Date: 2012-02-15 Impact factor: 3.756
Authors: Sofia El Manouni El Hassani; Daniel J C Berkhout; Hendrik J Niemarkt; Sarah Mann; Willem P de Boode; Veerle Cossey; Christian V Hulzebos; Anton H van Kaam; Boris W Kramer; Richard A van Lingen; Johannes B van Goudoever; Daniel C Vijlbrief; Mirjam M van Weissenbruch; Marc A Benninga; Nanne K H de Boer; Tim G J de Meij Journal: Neonatology Date: 2019-04-04 Impact factor: 4.035
Authors: Marita de Waard; Yanqi Li; Yanna Zhu; Adejumoke I Ayede; Janet Berrington; Frank H Bloomfield; Olubunmi O Busari; Barbara E Cormack; Nicholas D Embleton; Johannes B van Goudoever; Gorm Greisen; Zhongqian He; Yan Huang; Xiaodong Li; Hung-Chih Lin; Jiaping Mei; Paula P Meier; Chuan Nie; Aloka L Patel; Christian Ritz; Per T Sangild; Thomas Skeath; Karen Simmer; Olukemi O Tongo; Signe S Uhlenfeldt; Sufen Ye; Xuqiang Ye; Chunyi Zhang; Ping Zhou Journal: JPEN J Parenter Enteral Nutr Date: 2018-11-22 Impact factor: 4.016
Authors: Gregory P Goldstein; Vidya V Pai; Jessica Liu; Krista Sigurdson; Lelis B Vernon; Henry C Lee; Karl G Sylvester; Gary M Shaw; Jochen Profit Journal: Pediatr Res Date: 2020-08 Impact factor: 3.756